A new unit dedicated to clinical trials now open at Hartford Hospital is making life easier for cancer patients.
The latest addition is a four-bed, 1,650-square-foot unit at Hartford Hospital for patients in phase one cancer clinical trials.
Phase one studies of a new drug are usually the first that involve people. The main reason for doing this type of study is to find the highest dose of the new treatment that can be given safely without serious side effects. Although the treatment has been tested in lab and animal studies, the side effects in people can’t always be predicted. These studies also help to decide on the best way to give the new treatment.